Clinical utility of serial and continuous ST-segment recovery assessment in patients with acute ST-elevation myocardial infarction: assessing the dynamics of epicardial and myocardial reperfusion.
Krucoff
Mitchell W
MW
eECG Core Laboratory, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina, USA. kruco001@onyx.mc.duke.edu
Johanson
Per
P
Baeza
Ricardo
R
Crater
Suzanne W
SW
Dellborg
Mikael
M
D000077284:Abciximab; D000368:Aged; D000800:Angioplasty, Balloon; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006328:Cardiac Catheterization; D003131:Combined Modality Therapy; D003326:Coronary Circulation; D023903:Coronary Restenosis / Q000503:physiopathology; D003328:Coronary Thrombosis / Q000503:physiopathology / Q000628:therapy; D048909:Diabetes Complications; D004562:Electrocardiography; D017809:Fatal Outcome; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006321:Heart / Q000503:physiopathology; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D007387:Internal Mammary-Coronary Artery Anastomosis; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009203:Myocardial Infarction / Q000503:physiopathology* / Q000628:therapy; D015425:Myocardial Reperfusion; D009206:Myocardium; D010496:Pericardium / Q000503:physiopathology; D015607:Stents; D015912:Thrombolytic Therapy
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab